Skip to navigation bar Skip to breadcrumbs Skip to page content
clear place holder Envelope icon E-mail Updates Teal square Text size:  a A A

Gestational Diabetes Mellitus, Screening

Release Date: January 2014

Recommendation Summary

Summary of Recommendations and Evidence

PopulationRecommendationGrade
(What's This?)
Asymptomatic Pregnant Women, After 24 Weeks of Gestation

The USPSTF recommends screening for gestational diabetes mellitus (GDM) in asymptomatic pregnant women after 24 weeks of gestation. 

The USPSTF recommends the service. There is high certainty that the net benefit is moderate or there is moderate certainty that the net benefit is moderate to substantial.
Asymptomatic Pregnant Women, Before 24 Weeks of Gestation

The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for GDM in asymptomatic pregnant women before 24 weeks of gestation. 

The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of the service. Evidence is lacking, of poor quality, or conflicting, and the balance of benefits and harms cannot be determined.

Clinical Summary

Clinical summaries are one-page documents that provide guidance to primary care clinicians for using recommendations in practice.

This summary is intended for use by primary care clinicians.

 
Current as of: July 2015

Internet Citation: Final Update Summary: Gestational Diabetes Mellitus, Screening. U.S. Preventive Services Task Force. July 2015.
http://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/gestational-diabetes-mellitus-screening

USPSTF Program Office   540 Gaither Road, Rockville, MD 20850